As it happens in type 2 diabetes mellitus (DM2) and in metabolic syndrome (MS), when dysglycemia is present, GDM is associated to both insulin resistance and impaired insulin secretion [14-16]. The gene discussed is INS; the disease is myeloid sarcoma.